Q2 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Universe Pharmaceuticals(UPC) the Revenue is 4.518 M (-1.28%);the EBIT is -750.07 K (+35.53%);the EPS is -1.38 (+70.78%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B1.28%
----
----
EBIT
-0.00B35.53%
----
----
EPS
-1.3870.78%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf